Anzupgo (R) (delgocitinib cream) is currently approved in Canada, United States, European Union, United Kingdom, Switzerland and the United Arab Emirates under the brand name Anzupgo (R) for the ...

When searching for answers, expert advice matters. Here’s what dermatologists recommend to help caregivers confidently manage moderate to severe eczema in kids.

WATCH: November is eczema awareness month, Dr. Melinda Gooderham is a dermatologist and chronic hand eczema clinical researcher and explains early warning signs before symptoms become chronic.

Network meta-analysis of five studies compares chronic hand eczema monotherapies, ranking ten treatments by HECSI score ...

We hit the ice with history-making Olympic gold medalist Erin Jackson to talk eczema and EBGLYSS alongside Dr. Camille Howard ...

Recently, McMahan took the stage to discuss her struggles with the common skin condition at the Empowered With The Skin You’re In: Navigating Eczema & Sharing Moments of Clarity event hosted by ...

There are a few ingredients that can help treat dry patches. “I advise patients to look for products that contain hyaluronic ...

Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI. Chronic hand eczema (CHE) ...

Please provide your email address to receive an email when new articles are posted on . Chronic hand eczema affects nearly one in 10 U.S. adults. Prevalence rates are highest among men, employed ...

A new treatment for those suffering from "chronic" eczema is set to be available on the NHS within the next three months. More than 62,000 people in England suffering from debilitating hand eczema ...

Tens of thousands of people suffering from hand eczema could soon see their painful symptoms disappear, after the NHS today approved a pioneering new treatment. The twice-a-day cream can be used by ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...